Walking On Volume 6, Issue 10, October 2019 - Page 8

For the Health of It Guttural Pouch Mycosis Reprinted with permission from Equine Disease Quarterly, Volume 28, Number 4 Airway dysfunction is one of many causes of poor performance in equine athletes. Airway dysfunction can be classified as either acquired or developmental. One acquired dysfunction that is generally overlooked is a fungal infection of the guttural pouch, known as guttural pouch mycosis. Guttural pouch mycosis (GPM) is a potentially life-threatening disease that may initially present as a simple nosebleed (epistax- is) or even poor performance in an equine athlete. GPM has been documented in various parts of the United States, particularly in the southeast, as well as the United Kingdom. Clinical signs include unilateral (one-sided) or bilateral (both-sided) epistaxis, unilat- eral nasal discharge, dorsal displacement of the soft palate, dysphagia (difficulty swallowing), and laryngeal hemiplegia (partial or total paralysis of the larynx). Epistaxis occurs due to erosion of the guttural pouch mucosa by a fungal plaque, result- ing in hemorrhage from the internal carotid, occipital, or maxillary arter- ies. Severe hemorrhage may result in rapid death from exsanguination. Dysphagia as well as various forms of pharyngeal dysfunction in GPM result from muco- sal penetration and damage by fungal hyphae to the glossopharyngeal, hypoglossal, and/or the pharyngeal branches of the vagus nerves. A variety of fungi have been isolated from GPM with Aspergillus spp. being common. Aspergillus spp. and other opportunistic fungi are found naturally in the environment and can be found in the upper respiratory tract of normal hors- es. Wet environmental conditions, prolonged treat- ment with antimicrobials, an immunocompromised host, or use of corticosteroids have been proposed as factors conducive for fungal overgrowth. It is not fully understood why mycosis occurs in animals that are not immunosuppressed or debilitated. While no age predi- lection has been reported, the disease is more common in mature horses, but has been documented in foals as young as two months of age. Dysphagia is the second most common clinical sign associated with GPM, after epistaxis. The cranial nerves within the guttural pouch that innervate the pharynx are the glossopharyngeal, vagus, and hy- poglossal. Neurological dysfunction of the pharynx 8 • Walking On results when the nerves within the guttural pouch are inflamed or fibrosed. Generally, the presence of dys- phagia or other neurological deficits at presentation in- dicates a poor prognosis. The severity of cranial nerve deficits depends on whether nerve injury is restricted to a local neu-ritis or necrosis of the nerve secondary to fungal infiltration and fibrosis. Treatments include both medical and surgi- cal op- tions. While there are reports of successful medical treatment of GPM with systemic and topical antifungal medications, medical treat- ment is generally considered to be less efficacious than surgi- cal treatment. Topical treatments with enilconazole and miconazole have been used with success in some cases. The presence of a diptheritic membrane (necrot- ic material over the surface of the fungal plaque) may prevent penetration of systemic antifungals. Addition- ally, there is increased risk of fatal hemorrhage due to the longer course of medical treatment. The preferred method to treat severe guttural pouch mycosis is to surgically insert a coil or balloon into the affected blood vessel to quickly cut off the blood supply. Typ- ically, once the blood supply has been removed, the fungus regresses. CONTACT: Nathan Slovis, DVM, Dipl . ACVIM, CHT (Certified Hyperbaric Technologist) (859) 253-0002 Hagyard Equine Medical Institute Director McGee Critical Care and Medical Center Lexington, KY